Search Criteria: Cancer Studies;
A Special Program of Recovery for People with Bladder Cancer
(IRB#: IRB_00150155)
People diagnosed with bladder cancer who receive surgery often have some type of malnutrition (eating issue) that can make it harder to recover. A support program has been designed to see if it can reduce dietary problems from bladder cancer surgery. Research is needed to learn if the program improves the quality of life and reduces the risk of malnutrition. We want to know if the program is effective and improves a persons nutrition.
- All genders
- Over 18 years old
- Volunteers with special conditions
- From Home
- Paid
A Study to Help People Quit Smoking
(IRB#: IRB_00112287)
Tobacco use is the leading cause of death and disability in the U.S. that is preventable. Just-In-Time is a tool developed for preventing and treating addictions. Research is needed to know the effectiveness of the tool. The information we learn may aid future patients.
- All genders
- Over 18 years old
- Healthy Volunteers
- From Home
- Paid
Assess the Science of Daily Experiences and Quitting Smoking
(IRB#: IRB_00157042)
Tobacco is related to at least 20 different cancers. Most attempts to quit smoking fail. Technology has been developed to better understand how real-time experiences related to a persons identity and emotions impact efforts to quit smoking. Research is needed to assess the support people need to stop smoking. The information we learn may aid future patients.
- All genders
- Over 18 years old
- Healthy Volunteers
- From Home
- Paid
Assess the Science to Stop Smoking
(IRB#: IRB_00104596)
Tobacco is related to at least 20 different cancers. Most attempts to quit smoking fail. Technology has been developed to better understand how a persons emotions impact people in their efforts. Research is needed to assess the support people need to stop smoking. The information we learn may aid future patients.
- All genders
- Over 18 years old
- Healthy Volunteers
- From Home
- Paid
Cancer Stories Shaping Outcomes Can Your Cellphone Be a Compassionate Listener?
(IRB#: IRB_00143135)
This study is looking at cancer patient voices, actions and body language using computer measurements of behavior via video-recorded answers to questions on your smartphone device using a free app. This research is important because it may help us discover and understand unknown factors that impact cancer treatment outcomes.
- All genders
- Over 18 years old
- Volunteers with special conditions
- From Home
- Unpaid
CSL-964
(IRB#: IRB_00125273)
A study to evaluate the safety and efficacy of Alpha 1 Antitrypsin for the prevention of graft versus host disease in patients receiving hematopoietic cell transplant
- All genders
- Over 7 years old
- Volunteers with special conditions
- In Person
- Paid
Donor-Derived Ex-Vivo Expanded HaploNK Infusions for Children and Young Adults with High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell Transplant
(IRB#: IRB_00152764)
Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions is a procedure that may help children and young adults with high risk acute myeloid leukemia (AML) receiving Myeloablative HLA-Haploidentical Hematopoietic cell transplant. Research is needed to learn the safety and effectiveness of the process. The information we gain may aid future patients.
- All genders
- All Ages
- Volunteers with special conditions
- In Person
- Unpaid
Dual-Tracer Theranostic Position Emission Tomography (PET)
(IRB#: IRB_00158172)
Position Emission Tomography (PET) /CT scans are a way to see images inside of the body. Theranostics are a combination of using a radioactive drug to diagnose and a second radioactive drug to deliver therapy. Research is needed to develop methods that combine 2 different types of scans. These may be given to patients with neuroendocrine tumors and prostate cancer. The goal of the study is to eliminate the need to have the scans given separately and combine them into one patient health clinic visit.
- All genders
- Over 18 years old
- Volunteers with special conditions
- In Person
- Paid
FIREFLY-1
(IRB#: IRB_00138633)
The description and purpose of the study drug is to research the use of an investigational product labeled NA- IP (DAY 101- formerly TAK-580/MLN2480) to treat Low-Grade Glioma and other advanced solid tumors in pediatric and age-of-majority participants
- All genders
- All Ages
- Volunteers with special conditions
- In Person
- Paid
HCI-Total Cancer Care Study
(IRB#: IRB_00089989)
This study is a partnership between participants, health care providers, and researchers. Our aim is to better understand what causes cancer and to find better ways to prevent, detect, and treat cancer more successfully while also supporting your family. This study is an opportunity to contribute samples and information that will be used to accelerate cancer research and improve patient care. Participants like you are vital to our success. The study also offers access to a broader set of clinical trials and new treatments through our partnership with other leading cancer centers nationally. There is no cost to be in this study. No matter what you decide, it won't change the relationship with your health care providers to affect the quality of your care.
- All genders
- All Ages
- Healthy Volunteers
- From Home
- Paid
Improve How People Receive Cancer Information Online
(IRB#: IRB_00165673)
The goal of this study is to find out how cancer information from the internet makes people feel during their cancer experience. We want to know if it might guide patients choices about their treatment and manage cancer symptoms. Research is needed to learn better ways of helping patients find the best cancer information online. The information we gain may aid future patients.
- All genders
- Over 18 years old
- Volunteers with special conditions
- From Home
- Paid
Long-Term Follow-Up of Patients Who Received Lentiviral-Based CAR-T Cell Therapy
(IRB#: IRB_00079262)
People with specific types of cancer such as leukemia and lymphomas may receive Lentiviral-Based CAR-T Cell Therapy. This is to help improve the symptoms of this disease. Research is needed to learn the long-term safety and effectiveness of the therapy. The information we gain may provide further guidance to patients, doctors, and researchers.
- All genders
- Over 7 years old
- Volunteers with special conditions
- In Person
- Paid
PNOC-013 Study of Single Agent REGN2810 in Pediatric Patients with Relapsed or Refractory Solid or Central Nervous System (CNS) Tumors and a Safety and Efficacy Trial of REGN2810 in Combination with Radiotherapy in Pediatric Patients
(IRB#: IRB_00109601)
This study is being done to test if cemiplimab (study drug-REGN2810) can reduce the size of a tumor by helping the immune system destroy the tumor. The study is also being done to test the safety of cemiplimab in pediatric patients.
- All genders
- All Ages
- Volunteers with special conditions
- In Person
- Paid
Skin Cancer Prevention Education for Pregnant Mothers and Their New Babies
(IRB#: IRB_00150970)
Skin cancer is the most commonly diagnosed cancer in the United States. Parents are important in their childrens sun safety. Research is needed to find out how possible and effective it is to provide sun protection education to pregnant mothers. While studying the effects of the mothers sun protection actions. The information we learn will aid future patients.
- Female Only
- Under 7 or over 18 years old
- Healthy Volunteers
- From Home
- Paid
SUBLIME - Study of Utahns' Beliefs and Life Experiences with Integrative Medicine
(IRB#: IRB_00164305)
This study is evaluating Utah's Medical Cannabis Program. The study will survey people with and without a medical cannabis card. Currently, participants are only enrolling people without a medical cannabis card. People in this study will receive electronic surveys that will ask about their health. Surveys are completed at three different time points over one year. Questions are asked about physical, behavioral, and medical health.
- All genders
- Over 18 years old
- Volunteers with special conditions
- From Home
- Paid
Ultraviolet Ray Prevention for Children
(IRB#: IRB_00121617)
Melanoma is the 6th most common type of skin cancer in the United States. The just-in-time intervention (JITAI) application (app) is a tool used on a cell phone. The tool can help children and adults know how much time in ultraviolet rays (UVL) from the sun. Research is needed to learn what children and adults think about using the JITAI app. We hope to reduce the time children spend in UVR, so sunburns occur less.
- All genders
- Over 7 years old
- Healthy Volunteers
- From Home
- Paid